Whitebox Advisors’s AEON Biopharma Inc AEON.WS Stock Holding History

Whitebox Advisors’s Portfolio AEON.WS Stock Details AEON.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-92,000	Closed	-$133K	–	374
2024 Q1	$133K	Hold	92,000	–	–	﹤0.01%	163
2023 Q4	$9.19K	Hold	92,000	–	–	﹤0.01%	177
2023 Q3	$13.8K	Hold	92,000	–	–	﹤0.01%	186
2023 Q2	$8.28K	Hold	92,000	–	–	﹤0.01%	253
2023 Q1	$5.06K	Hold	92,000	–	–	﹤0.01%	416
2022 Q4	$4.2K	Hold	92,000	–	–	﹤0.01%	570
2022 Q3	$6K	Hold	92,000	–	–	﹤0.01%	708
2022 Q2	$14K	Hold	92,000	–	–	﹤0.01%	614
2022 Q1	$28K	Sell	92,000 -8,000	-8%	-$3.3K	﹤0.01%	655
2021 Q4	$51K	Buy	+100,000	New	+$55.3K	﹤0.01%	615

Whitebox Advisors's AEON.WS Position: Q2 2024 in Review

Whitebox Advisors sold out of AEON Biopharma Inc (AEON.WS) in Q2 2024, closing a stake of 92,000 shares — an estimated $133K sold.

Whitebox Advisors first reported a position in AEON.WS in Q4 2021 and held it in 10 quarters. The position peaked at $133K in Q1 2024. 0 funds tracked by Wall St. Rank hold AEON.WS as of Q2 2024.

Whitebox Advisors reported no remaining AEON Biopharma Inc position as of Q2 2024 after selling out during the quarter.
Whitebox Advisors sold 92,000 AEON Biopharma Inc shares in Q2 2024, an estimated $133K.
Whitebox Advisors first reported a position in AEON Biopharma Inc in Q4 2021 and held it in 10 quarters.
Whitebox Advisors's AEON Biopharma Inc position peaked at $133K in Q1 2024.
0 funds tracked by Wall St. Rank held AEON Biopharma Inc as of Q2 2024.

Based on Whitebox Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.